Zhu Y .2016 .Prevalence of gestational diabetes and risk of progression to type 2 diabetes: a global perspective. Curr Diab Rep, 16(1) : 7-15.
Diabetes Association American .2017 .Classification and diagnosis of diabetes. Diabetes Care, 40(Suppl 1) : .
Hectors TL,Vanparys C .2010 .Environmental pollutants and type 2 diabetes: a review of mechanisms that can disrupt beta cell function. Diabetologia, 54(6) : 1273-90.
. .. [PubMed] DOI: 10.1007/s00125-011-2109-5, : .
.2022 .Study the physiological, some biochemical, lipid profile status, and clinical markers in type 2 diabetes mellitus patients in AlNajaf Al-Ashraf Governorate. HIV Nurs, 22(2) : 3036-40.
Diabetes American . .Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2019.. , : .
Care Diabetes .2019 .. , 42(Suppl 1) : .
Hemmingsen B,Sonne DP,Metzendorf MI,Richter B .2016 .Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus. Cochrane Database Syst Rev, (10) : .
Huang Y,Cai X,Mai W,Li M,Hu Y. .2016 .Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis. BMJ, 355 : .
. .. , : .
Rosenstock J,Frias J,Páll D,Charbonnel B,Pascu R,Saur D .2018 .Effect of ertugliflozin on glucose control, body weight, blood pressure and bone density in type 2 diabetes mellitus inadequately controlled on metformin monotherapy (VERTIS MET). Diabetes Obes Metab, 20(3) : 520-9.
Marafie SK,Al-Mulla F SK .2023 .An overview of the role of furin in type 2 diabetes. Cells, 12(19) : 2407.
Furuhashi M. .2019 .Fatty acid-binding protein 4 in cardiovascular and metabolic diseases. J Atheroscler Thromb, 26(3) : 216-32.
Blüher M,Brennan AM,Kelesidis T,Kratzsch J,Fasshauer M,Kralisch S .2007 .Total and high-molecular weight adiponectin in relation to metabolic variables at baseline and in response to an exercise treatment program. Diabetes Care, 30 : 1362-5.
Dalius V,Vaidotas U,Zita AK,Agne A,Regina B .2008 .Adiponectin and insulin in pre-diabetes and early type 2 diabetes mellitus. Acta Medica Lituanica, 15(2) : 81-7.
Nam HK,Cho WK,Kim JH,Rhie YJ,Chung S,Lee KH .2018 .HbA1c cut-off for pre-diabetes and diabetes based on oral glucose tolerance test in obese children and adolescents. J Korean Med Sci, 33(12) : .
Yamamoto S,Matsushita Y,Nakagawa T,Hayashi T,Noda M,Mizoue T. .2014 .Circulating adiponectin levels and risk of type 2 diabetes in the Japanese. Nutr Diabetes, 4(8) : .
Osei K,Gaillard T,Schuster D .2005 .Plasma adiponectin levels in high risk African-Americans with normal glucose tolerance, impaired glucose tolerance, and type 2 diabetes. Obes Res, 13 : 179-85.
Bagheri R,Qasim AN,Mehta NN,Terembula K,Kapoor S,Braunstein S .2010 .Relation of plasma fatty acid binding proteins 4 and 5 with the metabolic syndrome, inflammation and coronary calcium in patients with type-2 diabetes mellitus. Am J Cardiol, 06 : 1118-23.
Hao Y,Ma X,Luo Y,Shen Y,Dou J,Pan X .2014 .Serum adipocyte fatty acid binding protein levels are positively associated with subclinical atherosclerosis in Chinese pre- and postmenopausal women with normal glucose tolerance. J Clin Endocrinol Metab, 99(11) : 1832-7.
Ishimura S,Furuhashi M,Watanabe Y,Hoshina K,Fuseya T,Mita T .2013 .Circulating levels of fatty acid-binding protein family and metabolic phenotype in the general population. PLoS One, 8(11) : .
Alexopoulou O,Bex M,Kamenicky P,Mvoula AB,Chanson P,Maiter D .2014 .Prevalence and risk factors of impaired glucose tolerance and diabetes mellitus at diagnosis of acromegaly: a study in 148 patients. , 17(1) : 81-9.
Jog KS,Eagappan S,Santharam RK,Subbiah S. .2023 .Comparison of novel biomarkers of insulin resistance with homeostasis model assessment of insulin resistance, its correlation to metabolic syndrome in South Indian population and proposition of population specific cut-offs for these indices. Cureus, 15(1) : .
Bahijri SM,Alissa EM,Akbar DH,Ghabrah TM .2010 .Estimation of insulin resistance in non-diabetic normotensive Saudi adults by QUICKI, HOMA-IR and modified QUICKI: a comparative study. Ann Saudi Med, 30 : 65252-4947.
Garin-Shkolnik T,Rudich A,Hotamisligil GS,Rubinstein M. .2014 .FABP4 attenuates PPAR and adipogenesis and is inversely correlated with PPAR in adipose tissues. Diabetes, 63 : 0436-11.